15 Ways Your Anxious Attachment Style Scares People Off
Anxious attachment isn't just about needing reassurance—it's about how that need shows up in ways you may not even realize. If you've ever felt like you're doing everything right in a relationship and still getting ghosted, pushed away, or misunderstood, your attachment style might be quietly sabotaging the connection. What feels like love, closeness, or attentiveness to you might come off as emotional intensity or pressure to someone else.
You don't mean to overwhelm someone—you just crave connection so deeply that you skip the build-up. You share vulnerable details quickly, offer intense validation, and expect the same back. But to someone with secure or avoidant attachment, this can feel like emotional whiplash.
What feels like closeness to you may feel like pressure to them. When intimacy isn't paced, people instinctively back away to protect their own boundaries.
You read into tone changes, word choices, and timing like your relationship depends on it. You're not paranoid—as highlighted by the Attachment Project, you're just hyperattuned to any perceived shift in affection. But this vigilance can feel like suspicion to the other person.
Instead of feeling safe, they start feeling scrutinized. Constant emotional audits make them feel like they're walking on eggshells.
You're not being dramatic—you just need to know they still care, especially when things feel uncertain. But constant 'Do you still love me?' or 'Are we okay?' moments can begin to sound like accusations instead of invitations. Eventually, your partner might feel like no answer is ever enough.
What soothes you in the short term may create long-term exhaustion for them. Reassurance loses its power when it becomes a ritual instead of a moment of connection.
When someone takes space, you interpret it as distance—or worse, disinterest. You try to close the gap quickly, hoping it'll make you feel safe again. But they just feel smothered.
To them, space is normal. To you, it's abandonment in disguise—and that disconnect quietly breaks the bond.
You say sorry preemptively, reflexively, sometimes before anyone's even upset. It's your subconscious way of saying, 'Please don't stop loving me.' But to others, it can come across as insecurity or emotional manipulation.
According to CNBC, over-apologizing can actually make people feel guilty, uncomfortable, or even annoyed. You're trying to protect the connection, but you're unknowingly eroding it.
Disagreements don't just feel tense—they feel threatening. As noted by Verywell Mind, even a minor argument can trigger your fear of abandonment. So you over-explain, people-please, or spiral.
This intensity can make people hesitant to be honest. They start hiding their real feelings—not to protect themselves, but to protect you.
You adjust your preferences, your personality, even your opinions to match theirs. It's not deception—it's survival. You've learned that being 'easy to love' means being low-maintenance.
But people fall for real people—not perfect reflections. Over time, they sense something's missing: you.
When a reply takes too long, your thoughts race: Did you say something wrong? Are they losing interest? That anxiety leads to checking their status, rereading messages, and maybe even sending more to 'check in.'
To them, it feels like pressure, not care. What you see as connection, they interpret as control.
You don't like leaving anything open-ended, especially if there's tension. So you chase closure—even when the other person needs a break. You're not trying to suffocate them, you're trying to settle your nervous system.
But that urgency can make them feel cornered. Sometimes people just need space to process without a performance review.
You ask personal questions fast, seek deep connection immediately, and share your heart fully. But instead of curiosity, it feels like interrogation. The intensity of your interest can feel invasive, even if it's well-meaning.
Some people need time to open up. Without space, intimacy can feel like a spotlight, not a safe place.
Your mind fills in emotional blanks with worst-case scenarios. When they say they need a night alone, your fear tells you they're pulling away. So you overcompensate—check in, double-text, worry aloud.
This can turn even healthy distance into drama. Your fear speaks louder than their actual words.
You're not just asking if they love you—you're asking if they still love you *today*. You check how they feel, what they think, where they stand. But constant emotional surveillance doesn't build closeness—it builds fatigue.
They may start withholding their real thoughts just to keep things calm. That's when communication starts breaking down.
When things are going well, you feel...off. You assume the silence is a buildup to something bad. Instead of enjoying the peace, you brace for impact.
People can feel that energy. And instead of deepening trust, it breeds tension.
You want to feel so close, so in sync, that their moods become yours. But this emotional fusion can feel like codependency. You're not loving them—you're dissolving into them.
Over time, they might feel like they're losing themselves in the relationship. Love doesn't mean losing your edges.
You perform: you over-give, over-share, over-function. You think love has to be earned, not received. So you become everything—until it's too much.
Eventually, people feel more pressure than connection. Love isn't about proving—it's about being.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
CEO of Sean Parker's breakthrough cancer drug institute on leading new race for cure
Karen Knudsen did not grow up in a scientifically centered home. She grew up in a military family. But at an early age, as a "naturally curious" kid, she came to love the experience of discovery and gravitated toward math and science. That led Knudsen to assume she would one day become a medical doctor. But her career went in another scientific direction, starting with a stint as a summer research intern working in the lab at the National Cancer Institute during the AIDS epidemic of the 1980s. "There was so much interest in trying to understand retrovirus like HIV, and so I went to a lab that was actually using retrovirus as a way to study cancer," she recalled in a recent interview with CNBC's Julia Boorstin for the CNBC Changemakers Spotlight series (Knudsen was named to the inaugural CNBC Changemakers list in 2024). "It got me very interested in that direct line. How does what I'm doing right now in the laboratory have an opportunity to impact a life, and I got hooked, and I never looked back," she said. Knudsen's experience as an oncology researcher at large health care systems, and seeing many mergers taking place around her, led to the realization that it might help to know more about the business of health care. She chose to pursue an MBA. "I'm not sure I'll forget the look on my husband when I came home one day and said, 'I'm going to get my MBA'," Knudsen recalled. "That was probably one of the more unexpected decisions." Ultimately, it led to Knudsen becoming the first female CEO of the more-than-century-old American Cancer Society, though she says it's even more important that she was the first CEO for the organization to come from oncology research. Under Knudsen's leadership, ACS's revenue increased by over 30%. Recently, Knudsen assumed the CEO post at the Parker Institute for Cancer Immunotherapy — created by Sean Parker, Facebook's first president and the tech entrepreneur behind breakthrough ideas like Napster — where a new philanthropy-meets-venture-capital business model that aligns with Knudsen's lifelong interest in discovery is being built. The mission hasn't changed: "In the U.S., we have 2.1 million Americans that are going to get a new cancer diagnosis this year, and unfortunately, 600,000 plus people who will die from one of the 200 diseases we call cancer," she said. While there has been a 34% decline in cancer mortality since 1991, primarily attributed to earlier detection and preventative health practices, Knudsen's new role places her at the forefront of efforts to fund a new generation of breakthrough cancer drugs. Knudsen spoke with CNBC's Boorstin about how she reached this stage of her career, and the lessons she has learned from a lifetime devoted to experimentation. Here are some highlights from the full video interview. As a scientist, Knudsen says, "You get very comfortable with hypothesis generation and testing," and that is in some ways similar to a business executive trying to figure out what is going to come next in their market, and how to remain successful as conditions change. Scientists get comfortable developing a set of success metrics that enable them to know quickly whether it's time to quit on a hypothesis or move ahead. Knudsen says that is part of the "overlapping mindset between being a scientist and being a business person" which has helped her to succeed as she moved from research into executive leadership. "It made the process of developing a set of success metrics and creating a business strategy that tells you when you may be onto something, or not, fairly easy," she said. As a researcher within health systems who saw firsthand how a wave of consolidation could reshape entities and raise the question of how every person, process and practice might need to change, Knudsen says you need to be ready to identify not only what works but also what needs to go away. Coming into the CEO post at ACS was "like coming into a fresh merger that was in need of business transformation," she said. "Finding opportunities and fixing what needs repairing is often the hardest part of leadership," she added. Knudsen took a hard look at a bureaucracy that over more than a century had grown into 12 separate organizations, with 12 CEOs and 12 strategies, and she made significant changes to streamline the operation. It wasn't all about rooting out the inefficiencies, though. "I was on the road 49 weeks of the year for four years in a row, because you really needed to be there to see what was so good in these various areas, and apply that to the rest of the organization," Knudsen said. Her larger point is that a lifetime in research has made her a leader who sees change as a constant. "Because medicine is changing, science is changing, technology will change ... It's okay to transform and to constantly iterate," she said. Sean Parker comes out of the Silicon Valley "move fast and break things" world of success, and Knudsen says she had learned to be "a little more confident at risk-taking" over the years. Working with Parker, who was the first president of Facebook and co-founder of Napster, is the culmination of the risk-taking business side of her mindset. "He's unafraid of thinking differently," Knudsen said, adding that he still embodies the idea that "if we're failing, let's fail fast." More specifically, she said Parker identified that lack of access to capital was a major impediment to progress in the fight against cancer, and that was holding the risk takers back from doing what they do best. "The whole philosophy of the Parker Institute is to, step one, collect the best brains. Give them investment in funding to do the high risk, high gain, cutting-edge research, which could fail but could also dramatically transform cancer therapy," she said. Founded in 2016 by Parker to turn all cancers into "curable diseases," the institute supports clinical testing, startup formation and incubation, and drug commercialization. In all, PICI has supported the work of 1,000 researchers and helped to create a $4 billion venture capital portfolio that includes 17 biotech companies. "I think it's because we've de-risked the science from the very beginning," Knudsen said. "We're not waiting for someone to pitch for us. So I'm feeling very bullish about the ability to crank this wheel," she said. Knudsen has had many mentors throughout her journey. One she cited was Nancy Brown, CEO of the American Heart Association, who she says was a "fountain of knowledge" to her. But as CEO of the American Cancer Society, she surrounded herself "with CEOs from all walks of life. I had a CEOs council that was hot dial," Knudsen said. "There are some things you just really need to talk to other CEOs about." She also emphasized that women pursuing success should expect to have to fight even harder for female representation the higher they ascend up a professional ladder. Statistically, that is the case whether in the business or academic world. More than 50% of both MD and PhD programs are filled with women, but only 12% become full professors, department chairs or deans. In the business world, 10% of women hold CEO positions in S&P 500 companies; and approximately 12% in VC-backed companies and 13% at health-care firms. The hurdles, whether it is related to gender, the inherent risk of failure in scientific endeavors, or lack of access to capital, are barriers that Knudsen's mission has helped her to overcome. "What I've always wanted to do, whether it's as a scientist, whether it's as a health executive, the CEO of the American Cancer Society or now the Parker Institute, it's to get innovation to people," she said. "We're at this moment in time where there is so much discovery that's happening, the pace of change is truly logarithmic, and yet, too many great ideas don't ever make it off the laboratory floor."
UPI
4 days ago
- UPI
Investors flock to Chinese herbal medicine stock with no revenues
Regencell Bioscience Holdings' NASDAQ stock price rallied with a 280% increase on Monday and another 25% on Tuesday after a recent 38-for-1 stock split took effect on Thursday. File Photo by Angelina Katsanis/UPI | License Photo June 17 (UPI) -- Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues. The stock split triggered a 280% share price increase on Monday, CNBC reported, and continued a 58,000% increase in its price in 2025, with a closing cost of $78 per share on the NASDAQ trading platform on Tuesday. The stock reached a high of $81.23 during morning trading and slumped slightly to $75.47 during Tuesday's after-hours trading. The stock is rated as a "buy" on the TipRanks website after Regencell officials on June 2 announced the stock split to improve its liquidity and value for shareholders. The stock split gave investors 37 shares for each share held on June 12. The shares began trading on a split-adjusted basis on Monday, according to Seeking Alpha. The firm has no reported revenue but says it is developing a Chinese herbal treatment for childhood attention deficit hyperactivity disorder and autism. The firm was established in 2014 and has been traded on NASDAQ under the RGC symbol since 202. It had a market capitalization of $29.7 billion at the end of trading on Monday. The market capitalization rose another 25% on Tuesday, with a total value of $36 billion. The stock traded for pennies per share last year but now has a greater market value than highly recognized businesses, including Kraft Heinz, Lululemon and eBay, according to CNBC. Part of the increased investor interest is due to Health and Human Services Secretary Robert Kennedy Jr. raising awareness of alternative medicines. Regencell Chief Executive Officer Yat-Gai Au controls more than 86% of the company's outstanding shares, according to FactSet. Little information is available about the potential effectiveness of the company's claims regarding its three traditional Chinese medicine formulas that are supposed to treat mild to severe forms of ADHD and autism with natural herbal medications in liquid form. Company officials in October reported no generated revenue and no regulatory approvals for its three liquid medicines. They reported net losses of $6.06 million in 2023 and $4.36 million in 2024. A Regencell patient case study in late 2023 said 28 patients were treated over three months during a second trial, which showed improvements in ADHD and autism. A dozen patients participated in a 2021 study to treat COVID-19, which indicated improvement in their symptoms.
CNBC
4 days ago
- CNBC
This one daily habit can boost brain health and help lower risk of dementia—it's 'very overlooked,' longevity doctor says
There are many things you can do to keep your brain sharp, from eating certain foods to playing memory games. But there's one daily practice for brain health that longevity doctor Dr. Avinish Reddy finds isn't talked about enough. "The thing that's very overlooked, which I'll always say, is exercise. Regular exercise reduces the risk of dementia," he says. "There's specific activities that lower your risk for Parkinson's and dementia as well, including racket sports like table tennis and pickleball. Because they use hand-eye coordination." Hand-eye coordination gets worse as people age because important areas of the brain can decline after the age of 60 without adequate exercise or nutrition, according to Harvard Health Publishing. Having good hand-eye coordination is necessary to remain independent, since it's important for activities like driving and grabbing a handrail, the publication noted. Playing racket sports like tennis and ping pong can improve hand-eye coordination because "the speed of the moving ball is challenging," occupational therapist Jennifer Packard told Harvard Health Publishing in 2021. "Your brain has to manage that hand and arm not just where you can see it, but also where you can't see it, as the ball flies by and you reach behind you or to the side." Engaging in team sports and group fitness activities can not only help you stay active, but they also increase social connection, Reddy notes. Research shows that meeting new people and maintaining personal relationships can improve your happiness and increase your chances of living longer. "I see patients that are older and if they get hurt, their first reason for wanting to get back exercising is because they're like, 'I want to go back and see my golf friends' or 'I want to go join my pickleball league again, to see my friends,'" he says. The largest age bracket of pickleball players was 55 and up in 2021, according to SFIA's 2022 Single Sport Participation Report on Pickleball. The social aspect of the sport is a huge draw, according to players who spoke to CNBC Make It in 2023. "I tell everyone I have made more friends and good acquaintances through pickleball within the last six to seven years than my lifetime," said Ryo Shinagawa, 72 at the time. Shinagawa played tennis for decades before pivoting to pickleball in 2016. He played pickleball three to four times a week, for about two to three hours, and connected with over 150 acquaintances through the sport. "It just makes you realize that exercise doesn't have to be that complicated," Reddy says. "And longevity doesn't have to be that complicated."
